Johnson & Johnson Cedes Control of Tylenol Plants to FDA

In a blow to Johnson & Johnson’s efforts to fix its public relations issues, the pharmaceutical manufacturer has turned over control of three of its manufacturing plants to the Food and Drug Administration. The transfer occurs in the wake of Tylenol product recalls as well as an ongoing criminal investigation concerning safety issues at the plant.
According to CNN, “McNeil, a division of Johnson & Johnson said it had agreed to put its plants — one in Las Piedras, Puerto Rico, one in Fort Washington, Pa. and one in Lancaster, Pa., under FDA supervision.”
Safety issues have not been limited Johnson & Johnson’s pharmaceutical divisions, however. DePuy, a subsidiary of Johnson & Johnson, has had to recall is DePuy ASR XL hip implant device for high failure rates and potential metallosis (metal poisoning) issues.